The divergence between primary and secondary glioblastomas, considered as two distinct entities, was supported strongest by the incidence of IDH mutations, which are presumed as early initiating events in the development of secondary glioblastomas either via astrocytic or oligoastrocytic progression. The gene discussed is IDH2; the disease is glioblastoma.